Chimeric Therapeutics Ltd. (AU:CHM) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Chimeric Therapeutics Ltd. is set to hold an Extraordinary General Meeting on December 4, 2024, both in-person and online, offering shareholders the chance to engage actively in the company’s strategic discussions. This meeting presents an opportunity for investors to stay informed and potentially influence the company’s future directions. Shareholders can participate virtually via a webcast or submit their votes using a proxy form.
For further insights into AU:CHM stock, check out TipRanks’ Stock Analysis page.